amazing how much effort GSK is now putting into boosting production of Relenza.
An Australian Company deriving 7% of sales from a product in demand worldwide. It is being under estimated by the market in my opinion
- Forums
- ASX - By Stock
- BTA
- glaxosmithkline update: influenza a (h1n1)
glaxosmithkline update: influenza a (h1n1), page-10
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)